Anti-neovasculature preparations for cancer
US7252824B2 · kind B2 · utility
5Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2002 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | Feb 13, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are immunogenic compositions, methods of designing immunogenic compositions, methods of treatment using immunogenic compositions, methods of evaluating cell-mediated immunity resulting from immunogenic compositions, research models, and methods of making research models, all of which relate to targeting tumor vasculature.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.